IRIS
RUSSO, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.228
NA - Nord America 5.413
AS - Asia 4.124
SA - Sud America 1.100
Continente sconosciuto - Info sul continente non disponibili 408
AF - Africa 107
OC - Oceania 11
Totale 17.391
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.233
RU - Federazione Russa 2.976
SG - Singapore 2.198
BR - Brasile 927
CN - Cina 895
IE - Irlanda 751
IT - Italia 738
SE - Svezia 479
HK - Hong Kong 374
DE - Germania 305
PL - Polonia 222
FR - Francia 220
FI - Finlandia 196
VN - Vietnam 183
IN - India 132
GB - Regno Unito 100
UA - Ucraina 80
CA - Canada 69
BD - Bangladesh 65
AR - Argentina 56
MX - Messico 48
TR - Turchia 40
EC - Ecuador 35
ID - Indonesia 31
JP - Giappone 31
ZA - Sudafrica 31
NL - Olanda 30
AT - Austria 25
BE - Belgio 25
IQ - Iraq 23
MA - Marocco 23
CI - Costa d'Avorio 22
CO - Colombia 21
UZ - Uzbekistan 20
ES - Italia 19
PK - Pakistan 19
VE - Venezuela 18
CL - Cile 16
LT - Lituania 13
AZ - Azerbaigian 12
CR - Costa Rica 11
KE - Kenya 11
JM - Giamaica 10
PY - Paraguay 10
CZ - Repubblica Ceca 9
DO - Repubblica Dominicana 9
HN - Honduras 9
PE - Perù 9
PH - Filippine 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
EU - Europa 8
MY - Malesia 8
TN - Tunisia 8
CH - Svizzera 7
IL - Israele 7
NP - Nepal 7
PT - Portogallo 6
GT - Guatemala 5
JO - Giordania 5
OM - Oman 5
TH - Thailandia 5
BH - Bahrain 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
LB - Libano 4
NI - Nicaragua 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AL - Albania 3
BO - Bolivia 3
EG - Egitto 3
GR - Grecia 3
IR - Iran 3
KW - Kuwait 3
PA - Panama 3
PR - Porto Rico 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BS - Bahamas 2
DM - Dominica 2
DZ - Algeria 2
GA - Gabon 2
KR - Corea 2
LK - Sri Lanka 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SN - Senegal 2
SV - El Salvador 2
AM - Armenia 1
BN - Brunei Darussalam 1
BW - Botswana 1
BZ - Belize 1
CY - Cipro 1
ET - Etiopia 1
Totale 16.979
Salva come PNG Salva come JPEG
Città #
Ashburn 939
Moscow 923
Singapore 802
Dublin 747
Chandler 540
Dallas 517
Hong Kong 374
Beijing 325
Nyköping 321
San Jose 305
Warsaw 220
Council Bluffs 208
Messina 206
Jacksonville 186
Munich 157
The Dalles 143
Princeton 128
Ann Arbor 121
Los Angeles 121
Lauterbourg 110
Medford 110
Helsinki 81
Des Moines 79
São Paulo 74
Cambridge 72
Ho Chi Minh City 70
Dearborn 67
New York 65
Buffalo 57
Tianjin 50
Boardman 48
Santa Clara 44
Bremen 41
Wilmington 38
Redondo Beach 37
Orem 35
Turku 35
Jinan 32
Pune 31
Rio de Janeiro 30
Frankfurt am Main 28
Chennai 27
Houston 27
Rome 25
Tokyo 25
Abidjan 22
Brooklyn 22
Curitiba 22
Hanoi 22
Hyderabad 22
Shenyang 22
Brussels 21
Guangzhou 21
Phoenix 21
Seattle 21
Atlanta 20
Catania 20
Chicago 19
Mexico City 19
Tashkent 19
Brasília 18
Johannesburg 18
Milan 18
Nanjing 17
Nuremberg 17
Woodbridge 17
Belo Horizonte 16
Denver 16
San Francisco 16
Zhengzhou 16
Hebei 15
Jakarta 15
London 15
Montreal 15
San Mateo 15
Toronto 15
Amsterdam 14
Campinas 14
Lappeenranta 14
Ningbo 14
Palermo 14
Shanghai 14
Porto Alegre 13
Shenzhen 13
Baku 12
Dong Ket 12
Duncan 12
Guayaquil 12
Lancaster 12
Quito 12
Taizhou 12
Changsha 11
Hangzhou 11
Vienna 11
Baghdad 10
Columbus 10
Istanbul 10
Poplar 10
Redwood City 10
Ribeirão Preto 10
Totale 9.480
Salva come PNG Salva come JPEG
Nome #
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 369
HATTR italian registry: preliminary data from the collaborative network of telethon GUP 15010 study 343
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 336
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 290
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 260
Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease 257
Clinical and pathological features of focal myositis 252
Etanercept for psoriasis and psoriatic arthritis in a patient with Charcot-Marie-Tooth disease 248
A Nouvel serum MicroRNA signature to screen ATTR 233
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 218
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 216
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 201
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 200
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 198
Alexithymia, burden and resilience in ALS’ caregivers 197
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 193
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy 185
Comparison Between 99mTc-Diphosphonate Imaging and MRI With Late Gadolinium Enhancement in Evaluating Cardiac Involvement in Patients With Transthyretin Familial Amyloid Polyneuropathy 184
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center 179
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 178
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 176
Bilateral paramedian thalamic infarct after occlusion of the artery of Percheron 175
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 173
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study. 172
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 171
Is overwork weakness relevant in Charcot-Marie-Tooth disease? 170
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 168
Autoimmune juvenile limb-girdle myasthenia 167
Parenteral nutrition improves nutritional status, autonomic symptoms and qol in patients with TTR-FAP 165
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study 162
Predictors of adaptation to non-invasive ventilation in amyotrophic lateral sclerosis 162
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 162
Psycological status and emotional burden in amyotrophic lateral sclerosis caregivers: the role of metacognitive processes. 160
Are novel outcome measures for Charcot–Marie–Tooth disease sensitive to change? The 6-minute walk test and StepWatch™ Activity Monitor in a 12-month longitudinal study 160
Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report 160
Emotional burden and coping strategies in amyotrophic lateral sclerosis caregivers: The role of metacognitions 159
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 158
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study 157
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry 157
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 155
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 151
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 151
The 6-min walk test as a new outcome measure in Amyotrophic lateral sclerosis 150
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study. 146
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis 146
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 145
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 145
Sport activity in Charcot-Marie-Tooth disease: A case study of a Paralympic swimmer 144
La deformazione longitudinale e radiale del ventricolo sinistro è ridotta nell’amiloidosi cardiaca familiare: studio con ecocardiogramma bi-dimensionale e risonanza magnetica cardiaca. 140
AUTONOMIC DYSFUNCTION AND HEART INVOLVEMENT IN TRANSTHYRETIN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY 137
Selective short-term verbal memory involvement in two siblings carrying centronuclear myopathy due to DNM2 gene mutations 137
MRI of cardiac involvement in transthyretin familial amyloid polyneuropathy 133
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS). 133
Facial onset sensory motor neuronopathy: not always a slowly progressive disorder. 132
Monitoring safety and effectiveness of tafamidis in transthyretin amyloidosis in italy. A 3-year longitudinal multicenter study in a non-endemic area. 131
CMT subtypes in a cohort of italian patients enrolled at Messina neuromuscular centre since 1994 to 2014. 131
Clinical spectrum and frequency of Charcot-Marie-Tooth disease in Italy: data from the national CMT registry 130
Considerable post-partum worsening in a patient with CMT2E 129
Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation 128
Phenotypic variability of TTR Val122Ile mutation: a Caucasian patient with axonal neuropathy and normal heart 127
The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury 125
TRANSTHYRETIN AMYLOIDOSIS IN SOUTHERN ITALY POPULATION: DESCRIPTION OF A COHORT OF PATIENTS WITH PHE64LEU MUTATION AND LATE ONSET 124
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 122
Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone 118
Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: neurological and cardiological features 118
Neurological data collection protocol on tafamidis meglumine treatment for familial amyloid polyneuropathy: preliminary data on patients enrolled by the italian network 117
Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area (Journal of Neurology, DOI: 10.1007/s00415-016-8064-9) 116
Factors predicting survival in ALS: a multicenter Italian study 112
Miopatia prossimale in paziente con sindrome di Williams 110
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy 109
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response? 108
Safety and tolerability of orally administered tafamidis meglumine in TTR FAP: preliminary data at 3-month follow-up 108
Efficacy and quality of life in patients with multifocal motor neuropathy treated by subcutaneous immunoglobulin. 108
Correction to: Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 105
Psychosocial impact of presymptomatic genetic testing for transthyretin amyloidotic polyneuropathy 104
Very Early Onset of ATTRE89Q Amyloidosis in a Homozygous Patient 104
Corneal Sub-Basal Nerve Plexus in Non-Diabetic Small Fiber Polyneuropathies and the Diagnostic Role of In Vivo Corneal Confocal Microscopy 103
Repurposing chemotherapy-induced peripheral neuropathy grading 101
L'inibizione dei pathway del fattore nucleare-kappaB, delle MAP chinasi e di COX/5-LOX mediante trattamento con flavocoxid migliora la funzione e la morfologia muscolare nel topo mdx: uno studio comparativo con il metilprednisolone 100
HATTR : Neurotrophic factors expression in schwann cell line after MIR-150 transfection. 100
The THAOS: record of patients from our site. 96
Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy 94
From a misdiagnosis of anorexia nervosa to a dramatic patisiran-induced improvement in a patient with ATTRE89Q amyloidosis 94
hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers 94
Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation 92
Variable phenotypes are associated with PM22 missense mutations. 92
Pregnancy in Charcot-Marie-Tooth disease: Data from the Italian CMT national registry 91
Left atrial function in cardiac amyloidosis 90
Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years 90
Phenotypic spectrum of myelin protein zero-related neuropathies: a large cohort study from five mutation clusters across Italy 88
Molecular profile of transthyretin related familial amyloidotic polyneuropathy: a microarray analysis. 88
Nuclear factor-kappaB, mitogen-activated protein kinases and cyclooxygenase/5-lipoxygenase pathway inhibition by flavocoxid improves muscle function and morphology in mdx mice: a comparison study with methylprednisolone. 88
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: Secondary analysis of data from the CI-PeriNomS study 88
The role of metacognitive beliefs on anxiety and depression among Amyotrophic Lateral Sclerosis caregivers 88
Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset. 88
Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy 87
Impact of vutrisiran on quality of life and physical function in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy 86
Correlation between morphologic and functional echocardiographic indexes and semiquantitative analysis of 99mTC-DPD scintigraphy in patients with transthyretin related amyloidosis 85
TRANSTHYRETIN AMYLOIDOSIS IN SOUTHERN ITALY POPULATION: DESCRIPTION OF A COHORT OF PATIENTS WITH PHE64LEU MUTATION AND LATE ONSET 85
Systematic investigation on needs and use of technological device in amyotrophic lateral sclerosis patients and caregivers: a natinwide, multicentre survey. 84
Totale 14.792
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.826
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.826
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022740 0 89 5 30 49 11 74 41 26 50 59 306
2022/20232.033 165 185 110 149 158 169 20 94 912 7 43 21
2023/2024517 42 77 26 38 53 121 20 32 7 35 15 51
2024/20253.588 46 52 64 177 146 128 186 551 643 170 655 770
2025/20267.907 402 605 585 539 695 1.548 987 954 894 394 150 154
2026/2027552 244 308 0 0 0 0 0 0 0 0 0 0
Totale 17.391